DSP Healthcare Fund

DSP Mutual Fund · Sectoral / Thematic · Direct Growth · AMFI 145454 · ISIN INF740KA1LG1
NAV₹52.068019 Nov 2026
3Y return+20.55%a year
5Y return+16.95%a year
Expense ratio0.75%₹3,727 Cr
Growth Score86.0★★★★★

Returns

1M3M6MYTD1Y3Y5Y7Y10YSince launch
Fund+7.69%+1.76%+14.37%+19.60%+19.07%+20.55%+16.95%+25.26%—+22.93%
NIFTY Healthcare TRI+12.35%+6.16%+10.59%+20.00%+18.07%+20.97%+15.83%———
Category middle+7.06%+0.76%+8.56%+4.78%+4.51%+14.52%+13.44%+17.70%+15.67%—

Risk (36 months)

Volatility14.23%
Sharpe0.99
Sortino1.67
Beta0.79
Alpha+2.14%
Deepest fall-21.74%
1-year periods with a loss19%
5Y SIP XIRR+19.93%

Top holdings (31 Oct 2026)

Apollo Hospitals Enterprise Limited7.89%
IPCA Laboratories Limited7.49%
Cipla Limited7.40%
Sun Pharmaceutical Industries Limited7.32%
Gland Pharma Limited6.61%
Sai Life Sciences Limited6.17%
Globus Medical Inc5.36%
Alkem Laboratories Limited4.73%
Divi's Laboratories Limited4.41%
Cohance Lifesciences Limited3.82%
Alembic Pharmaceuticals Limited3.09%
Thyrocare Technologies Limited2.84%

Sectors

Pharmaceuticals & Biotechnology66.0%
Healthcare Services20.8%
Healthcare Equipment & Supplies9.0%
Foreign Security1.1%
Insurance1.0%

Calculated by Growth Analyser from AMFI NAVs and the fund house's disclosed portfolio. Up to 1 year: total return; longer: CAGR. Research and education only; not investment advice. Mutual fund investments are subject to market risks; read all scheme-related documents carefully. Past performance does not indicate future returns.